Clinical trial
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to…
NCT00236301 · Assistance Publique - Hôpitaux de Paris, Other · Terminated
Key facts
| NCT number | NCT00236301 |
|---|---|
| Title | Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers |
| Official title | Pro-Inflammatory Effects of Two Different Doses of 17 Beta Estradiol in Menopausal Women |
| Acronym | THS |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | French Health Products Safety Agency FRM Solvay Pharmaceuticals Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy Symptomatic Menopausal Women |
| Intervention type | Drug |
| Interventions | CLIMASTON (drug), 17 Beta-estradiol (2mg/day)and (1mg/day), placebo |
| Enrollment | 99 |
| Start date | Mar 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Oct 12, 2005 |
| Last update posted | Jan 17, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: